Business
Zydus Lifesciences Limited Press Release Jan 16 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 16, 2023, titled "Zydus receives tentative approval from the USFDA forLevomilnacipran Extended-Release Capsules".

About this update from Zydus Lifesciences Limited
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 16, 2023, titled "Zydus receives tentative approval from the USFDA forLevomilnacipran Extended-Release Capsules". View Attachment
View stock analysis, news, and events for Zydus Lifesciences Limited